MetaADEDB 2.0 @ LMMD
Esomeprazole
(SUBDBMMJDZJVOS-DEOSSOPVSA-N)
Structure
SMILES
COc1ccc2c(c1)[nH]c(n2)[S@@](=O)Cc1ncc(c(c1C)OC)C
Type(s)
Approved; Investigational
ATC code(s)
A02BC05; A02BD06; M01AE52
Molecular Formula:
C17H19N3O3S
Molecular Weight:
345.416
Log P:
3.7654
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
96.31
CAS Number(s):
119141-88-7; 326602-80-6
Synonym(s)
1.
Esomeprazole
2.
Esomeprazole Magnesium
3.
Esomeprazole Potassium
4.
Esomeprazole Sodium
5.
Esomeprazole Strontium
6.
Esomeprazole Strontium Anhydrous
7.
Nexium
8.
Strontium, Esomeprazole
External Link(s)
MeSHD064098
PubChem Compound9568614
ChEBI50275
CHEMBLCHEMBL1201320
DrugBankDB00736
DrugCentral1055
IUPHAR/BPS Guide to PHARMACOLOGY5488
KEGGdr:D07917
Therapeutic Target DatabaseD0C6DT
ZINC4693575
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug dose omissionFAERS: 793US FAERS
2Acute kidney injuryFAERS: 759US FAERS
3Drug ineffectiveFAERS: 516
Canada Vigilance: 249
Canada Vigilance
US FAERS
4DyspepsiaFAERS: 428
Canada Vigilance: 40
Canada Vigilance
SIDER
US FAERS
5MalaiseFAERS: 416
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
6Intentional product misuseFAERS: 370US FAERS
7OsteoporosisFAERS: 362
Canada Vigilance: 1
Canada Vigilance
US FAERS
8Rebound acid hypersecretionFAERS: 300US FAERS
9PainFAERS: 235
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
10Bone density decreasedFAERS: 231US FAERS
11Intentional drug misuseFAERS: 222US FAERS
12VomitingFAERS: 202
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
13Abdominal discomfortFAERS: 195
Canada Vigilance: 7
Canada Vigilance
US FAERS
14Product use issueFAERS: 162
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Feeling abnormalFAERS: 147SIDER
US FAERS
16NauseaFAERS: 140
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
17Adverse eventFAERS: 131US FAERS
18Chest PainFAERS: 119
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
19HeadacheFAERS: 84
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
20Throat irritationFAERS: 80
Canada Vigilance: 5
Canada Vigilance
US FAERS
21Weight decreasedFAERS: 80
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
22UlcerFAERS: 79
Canada Vigilance: 2
Canada Vigilance
US FAERS
23Product substitution issueFAERS: 76
Canada Vigilance: 41
Canada Vigilance
US FAERS
24AphagiaFAERS: 75US FAERS
25Oropharyngeal painFAERS: 59
Canada Vigilance: 5
Canada Vigilance
US FAERS
26Product quality issueFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
27Intentional product use issueFAERS: 57US FAERS
28NasopharyngitisFAERS: 56US FAERS
29RegurgitationFAERS: 56US FAERS
30Abdominal PainFAERS: 53
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
31Diabetes MellitusFAERS: 53US FAERS
32Chest discomfortFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
33DizzinessFAERS: 46
Canada Vigilance: 20
Canada Vigilance
SIDER
US FAERS
34DiscomfortFAERS: 45
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
35AnxietyFAERS: 44
Canada Vigilance: 5
Canada Vigilance
US FAERS
36ArthritisFAERS: 44SIDER
US FAERS
37Burning sensationFAERS: 44
Canada Vigilance: 5
Canada Vigilance
US FAERS
38HyperchlorhydriaFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
39HypersensitivityFAERS: 42
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
40Myocardial InfarctionFAERS: 42
Canada Vigilance: 3
Canada Vigilance
US FAERS
41ArthralgiaFAERS: 41
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
42FlatulenceFAERS: 41
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
43Memory impairmentFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
44Back PainFAERS: 40
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
45Cerebrovascular accidentFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
46EructationFAERS: 39
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
47InfluenzaFAERS: 36US FAERS
48ConstipationFAERS: 34
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
49DysphoniaFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Sleep disorder due to general medical condition, insomnia typeFAERS: 34US FAERS
51Blood magnesium decreasedFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
52FatigueFAERS: 32
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
53PneumoniaFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
54AstheniaFAERS: 30
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
55Irritable Bowel SyndromeFAERS: 30US FAERS
56BronchitisFAERS: 29US FAERS
57DysgeusiaFAERS: 29
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
58Product use in unapproved indicationFAERS: 29US FAERS
59StressFAERS: 29US FAERS
60Circumstance or information capable of leading to medication errorFAERS: 28US FAERS
61ChokingFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Gastric ulcerFAERS: 27SIDER
US FAERS
63UrticariaFAERS: 27
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
64Activities of daily living impairedFAERS: 25US FAERS
65HerniaFAERS: 25SIDER
US FAERS
66GastritisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
67NephrolithiasisFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
68PalpitationsFAERS: 22
Canada Vigilance: 8
Canada Vigilance
US FAERS
69PruritusFAERS: 22
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
70HypophagiaFAERS: 21US FAERS
71Sleep disorder due to a general medical conditionFAERS: 21US FAERS
72Therapy cessationFAERS: 21US FAERS
73Visual ImpairmentFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
74AmnesiaFAERS: 20US FAERS
75DehydrationFAERS: 20
Canada Vigilance: 4
Canada Vigilance
US FAERS
76DiverticulitisFAERS: 20US FAERS
77MalabsorptionFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
78MyalgiaFAERS: 20
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
79Therapeutic response unexpectedFAERS: 20US FAERS
80AlopeciaFAERS: 19SIDER
US FAERS
81Disease recurrenceFAERS: 19US FAERS
82Joint injuryFAERS: 19US FAERS
83OsteopeniaFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
84TremorFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
85CryingFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
86Drug DependenceFAERS: 17US FAERS
87Rebound effectFAERS: 17US FAERS
88FibromyalgiaFAERS: 16SIDER
US FAERS
89FractureFAERS: 16US FAERS
90Blood cholesterol increasedFAERS: 15US FAERS
91LaryngitisFAERS: 15US FAERS
92RetchingFAERS: 15US FAERS
93RhabdomyolysisFAERS: 15US FAERS
94Ankle FractureFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
95DementiaFAERS: 14US FAERS
96General physical health deteriorationFAERS: 14US FAERS
97Multiple allergiesFAERS: 14US FAERS
98Product dose omissionFAERS: 14US FAERS
99Back disorderFAERS: 13US FAERS
100Blood potassium decreasedFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
101Musculoskeletal PainFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
102VertigoFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
103AphoniaFAERS: 12US FAERS
104ArthropathyFAERS: 12SIDER
US FAERS
105Impaired gastric emptyingFAERS: 12US FAERS
106Incorrect dose administeredFAERS: 12US FAERS
107SinusitisFAERS: 12SIDER
US FAERS
108Urinary tract infectionFAERS: 12US FAERS
109AsthmaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
110Drug ineffective for unapproved indicationFAERS: 11US FAERS
111Impaired work abilityFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
112Limb injuryFAERS: 11US FAERS
113Peripheral swellingFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
114Clostridium difficile infectionFAERS: 10US FAERS
115Drug prescribing errorFAERS: 10US FAERS
116Emotional distressFAERS: 10US FAERS
117Incorrect drug administration durationFAERS: 10US FAERS
118NervousnessFAERS: 10
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
119PancreatitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
120Rheumatoid ArthritisFAERS: 10US FAERS
121SwellingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Therapeutic response changedFAERS: 10US FAERS
123Bone painFAERS: 9US FAERS
124ChillsFAERS: 9SIDER
US FAERS
125DeafnessFAERS: 9US FAERS
126Diabetic KetoacidosisFAERS: 9US FAERS
127Food AllergyFAERS: 9US FAERS
128Intestinal ObstructionFAERS: 9US FAERS
129Oral painFAERS: 9US FAERS
130OverdoseFAERS: 9US FAERS
131SepsisFAERS: 9US FAERS
132SomnolenceFAERS: 9
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
133Vitamin D DeficiencyFAERS: 9US FAERS
134nervous system disorderFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Blood glucose increasedFAERS: 8US FAERS
136CataractFAERS: 8US FAERS
137ErythemaFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
138Gluten sensitivityFAERS: 8US FAERS
139Musculoskeletal discomfortFAERS: 8SIDER
US FAERS
140Nerve injuryFAERS: 8US FAERS
141Oropharyngeal discomfortFAERS: 8US FAERS
142Reaction to drug excipientsFAERS: 8US FAERS
143ThrombosisFAERS: 8US FAERS
144Atrial FibrillationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
145Bowel movement irregularityFAERS: 7US FAERS
146Choking sensationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
147ColitisFAERS: 7US FAERS
148DisabilityFAERS: 7US FAERS
149Drug administered to patient of inappropriate ageFAERS: 7US FAERS
150Drug effect incompleteFAERS: 7US FAERS
151Electrolyte imbalanceFAERS: 7US FAERS
152EpilepsyFAERS: 7US FAERS
153Feeling jitteryFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
154Gastric pH decreasedFAERS: 7US FAERS
155Inappropriate schedule of drug administrationFAERS: 7US FAERS
156Infantile spitting upFAERS: 7US FAERS
157Insurance issueFAERS: 7US FAERS
158Joint swellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Limb discomfortFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
160Neck PainFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
161Product physical issueFAERS: 7US FAERS
162Productive CoughFAERS: 7US FAERS
163TetanyFAERS: 7US FAERS
164TinnitusFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
165Toxic Epidermal NecrolysisFAERS: 7SIDER
US FAERS
166AgitationFAERS: 6SIDER
US FAERS
167CholelithiasisFAERS: 6US FAERS
168Depressed moodFAERS: 6US FAERS
169Drug dispensing errorFAERS: 6US FAERS
170Erythema MultiformeFAERS: 6SIDER
US FAERS
171Escherichia infectionFAERS: 6US FAERS
172Gastrointestinal PainFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
173Gastrointestinal inflammationFAERS: 6US FAERS
174Gastrointestinal ulcerFAERS: 6US FAERS
175Impaired driving abilityFAERS: 6US FAERS
176Lip swellingFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
177Magnesium DeficiencyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Musculoskeletal stiffnessFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Osteogenesis ImperfectaFAERS: 6US FAERS
180Pancreatic carcinomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Product taste abnormalFAERS: 6US FAERS
182SyncopeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
183AbasiaFAERS: 5US FAERS
184Atypical pneumoniaFAERS: 5US FAERS
185BlindnessFAERS: 5US FAERS
186Calcium deficiencyFAERS: 5US FAERS
187Drug effect delayedFAERS: 5US FAERS
188DysarthriaFAERS: 5US FAERS
189Emotional disorderFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Extra dose administeredFAERS: 5US FAERS
191HungerFAERS: 5US FAERS
192Intervertebral Disc DegenerationFAERS: 5US FAERS
193MYELODYSPLASTIC SYNDROMEFAERS: 5US FAERS
194Mental impairmentFAERS: 5US FAERS
195No adverse eventFAERS: 5US FAERS
196PancytopeniaFAERS: 5SIDER
US FAERS
197Peptic UlcerFAERS: 5US FAERS
198Poor quality sleepFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
199PsoriasisFAERS: 5US FAERS
200Renal painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
201ScreamingFAERS: 5US FAERS
202Status EpilepticusFAERS: 5US FAERS
203Suspected counterfeit productFAERS: 5US FAERS
204TachycardiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
205Urinary RetentionFAERS: 5US FAERS
206jaundiceFAERS: 5SIDER
US FAERS
207Acute myocardial infarctionFAERS: 4US FAERS
208AngerFAERS: 4US FAERS
209Apparent deathFAERS: 4US FAERS
210Blood calcium abnormalFAERS: 4US FAERS
211Blood chromogranin A increasedFAERS: 4US FAERS
212Blood magnesium abnormalFAERS: 4US FAERS
213Blood urine presentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
214Bone density abnormalFAERS: 4US FAERS
215ChromaturiaFAERS: 4US FAERS
216Dental cariesFAERS: 4US FAERS
217EpistaxisFAERS: 4SIDER
US FAERS
218GlaucomaFAERS: 4US FAERS
219HypothyroidismFAERS: 4US FAERS
220Increased upper airway secretionFAERS: 4US FAERS
221InflammationFAERS: 4US FAERS
222Lactose IntoleranceFAERS: 4US FAERS
223LeukopeniaFAERS: 4SIDER
US FAERS
224Lupus-like syndromeFAERS: 4US FAERS
225Medication residue presentFAERS: 4US FAERS
226Middle insomniaFAERS: 4US FAERS
227NeutropeniaFAERS: 4US FAERS
228Non-cardiac chest painFAERS: 4US FAERS
229Reflux gastritisFAERS: 4US FAERS
230Respiratory tract congestionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Respiratory tract irritationFAERS: 4US FAERS
232SneezingFAERS: 4US FAERS
233Throat cancerFAERS: 4US FAERS
234Tooth LossFAERS: 4US FAERS
235Unevaluable eventFAERS: 4US FAERS
236WheezingFAERS: 4US FAERS
237Wrong technique in product usage processFAERS: 4US FAERS
238AcidosisFAERS: 3US FAERS
239Amyotrophic Lateral SclerosisFAERS: 3US FAERS
240AngioedemaFAERS: 3SIDER
US FAERS
241ArteriosclerosisFAERS: 3US FAERS
242Bipolar DisorderFAERS: 3US FAERS
243Blood count abnormalFAERS: 3US FAERS
244Blood creatinine increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
245Blood gastrin increasedFAERS: 3SIDER
US FAERS
246Blood glucose abnormalFAERS: 3US FAERS
247Blood sodium decreasedFAERS: 3US FAERS
248BursitisFAERS: 3US FAERS
249Carpal Tunnel SyndromeFAERS: 3US FAERS
250Chronic gastritisFAERS: 3US FAERS
251CyanosisFAERS: 3US FAERS
252Device occlusionFAERS: 3US FAERS
253DiplopiaFAERS: 3US FAERS
254Duodenal UlcerFAERS: 3US FAERS
255DysuriaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
256Ear discomfortFAERS: 3US FAERS
257Flank PainFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
258Food cravingFAERS: 3US FAERS
259FormicationFAERS: 3US FAERS
260Gastrointestinal motility disorderFAERS: 3US FAERS
261Gastrointestinal sounds abnormalFAERS: 3US FAERS
262Gastrooesophageal sphincter insufficiencyFAERS: 3US FAERS
263General symptomFAERS: 3US FAERS
264GoutFAERS: 3US FAERS
265HypersomniaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
266InfarctionFAERS: 3US FAERS
267InfectionFAERS: 3SIDER
US FAERS
268Iron deficiencyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
269Joint stiffnessFAERS: 3US FAERS
270LaryngospasmFAERS: 3US FAERS
271LethargyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Long QT SyndromeFAERS: 3US FAERS
273Maternal exposure during pregnancyFAERS: 3US FAERS
274Multiple SclerosisFAERS: 3US FAERS
275Muscle tightnessFAERS: 3US FAERS
276Musculoskeletal chest painFAERS: 3US FAERS
277Night sweatsFAERS: 3US FAERS
278Precancerous cells presentFAERS: 3US FAERS
279Precancerous mucosal lesionFAERS: 3US FAERS
280Product difficult to swallowFAERS: 3US FAERS
281Product packaging issueFAERS: 3US FAERS
282Product solubility abnormalFAERS: 3US FAERS
283Renal cystFAERS: 3US FAERS
284Respiratory FailureFAERS: 3US FAERS
285RestlessnessFAERS: 3US FAERS
286SciaticaFAERS: 3US FAERS
287Septic ShockFAERS: 3US FAERS
288StomatitisFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
289ThirstFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
290Tongue blisteringFAERS: 3US FAERS
291Tooth ErosionFAERS: 3US FAERS
292Upper-airway cough syndromeFAERS: 3US FAERS
293Wrong patient received medicationFAERS: 3US FAERS
294Abdominal tendernessFAERS: 2US FAERS
295Accidental exposure to product by childFAERS: 2US FAERS
296AgeusiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
297AgoraphobiaFAERS: 2US FAERS
298Allergy to chemicalsFAERS: 2US FAERS
299Anaphylactic shockFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
300Anorectal discomfortFAERS: 2SIDER
US FAERS
301AphasiaFAERS: 2US FAERS
302AppendicitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
303AtaxiaFAERS: 2US FAERS
304Atrial FlutterFAERS: 2US FAERS
305Autoimmune hepatitisFAERS: 2US FAERS
306BlepharospasmFAERS: 2US FAERS
307Blood creatine phosphokinase increasedFAERS: 2US FAERS
308Blood iron abnormalFAERS: 2US FAERS
309Blood iron decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
310Blood iron increasedFAERS: 2US FAERS
311BronchopneumoniaFAERS: 2US FAERS
312BronchospasmFAERS: 2SIDER
US FAERS
313BruxismFAERS: 2US FAERS
314Cardiac ArrestFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
315Cartilage injuryFAERS: 2US FAERS
316Cerebral atrophyFAERS: 2US FAERS
317ClaustrophobiaFAERS: 2US FAERS
318Clostridium test positiveFAERS: 2US FAERS
319Coronary Artery DiseaseFAERS: 2US FAERS
320CystitisFAERS: 2SIDER
US FAERS
321DeliriumFAERS: 2US FAERS
322DermatitisFAERS: 2SIDER
US FAERS
323Disease ProgressionFAERS: 2US FAERS
324DisorientationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
325DiverticulumFAERS: 2US FAERS
326Drug screen positiveFAERS: 2US FAERS
327Drug withdrawal syndromeFAERS: 2US FAERS
328Economic problemFAERS: 2US FAERS
329EncephalitisFAERS: 2US FAERS
330EndometriosisFAERS: 2US FAERS
331Epigastric discomfortFAERS: 2US FAERS
332Expired product administeredFAERS: 2US FAERS
333Eye irritationFAERS: 2US FAERS
334False positive investigation resultFAERS: 2US FAERS
335FlushingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
336Gastric infectionFAERS: 2US FAERS
337Gastric pH increasedFAERS: 2US FAERS
338Gastrointestinal infectionFAERS: 2US FAERS
339Gastrointestinal mucosal disorderFAERS: 2US FAERS
340General physical condition abnormalFAERS: 2US FAERS
341GlossitisFAERS: 2US FAERS
342Heat StrokeFAERS: 2US FAERS
343HemiplegiaFAERS: 2US FAERS
344Hernia painFAERS: 2US FAERS
345HydrocephalusFAERS: 2US FAERS
346HyperphagiaFAERS: 2US FAERS
347HypokinesiaFAERS: 2US FAERS
348HypoparathyroidismFAERS: 2US FAERS
349HypotensionFAERS: 2US FAERS
350Immune thrombocytopenic purpuraFAERS: 2US FAERS
351Inability to afford medicationFAERS: 2US FAERS
352Incorrect product storageFAERS: 2US FAERS
353Infrequent bowel movementsFAERS: 2US FAERS
354Intentional dose omissionFAERS: 2US FAERS
355Joint Range of Motion DecreasedFAERS: 2US FAERS
356Kounis SyndromeFAERS: 2US FAERS
357LabyrinthitisFAERS: 2US FAERS
358Ligament injuryFAERS: 2US FAERS
359LymphomaFAERS: 2US FAERS
360Malignant neoplasm progressionFAERS: 2US FAERS
361MalnutritionFAERS: 2US FAERS
362MonoplegiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
363Negative thoughtsFAERS: 2US FAERS
364NeuralgiaFAERS: 2US FAERS
365NoduleFAERS: 2SIDER
US FAERS
366Obsessive thoughtsFAERS: 2US FAERS
367Ocular icterusFAERS: 2US FAERS
368Panic DisorderFAERS: 2US FAERS
369ParanoiaFAERS: 2US FAERS
370PeriarthritisFAERS: 2US FAERS
371Peripheral arterial occlusive diseaseFAERS: 2US FAERS
372PharyngitisFAERS: 2SIDER
US FAERS
373PleurothotonusFAERS: 2US FAERS
374Post procedural complicationFAERS: 2US FAERS
375Post-Traumatic Stress DisorderFAERS: 2US FAERS
376Product contaminationFAERS: 2US FAERS
377Pulmonary FibrosisFAERS: 2US FAERS
378Renal ColicFAERS: 2US FAERS
379Renal tubular necrosisFAERS: 2US FAERS
380Respiratory arrestFAERS: 2US FAERS
381Retinal DetachmentFAERS: 2US FAERS
382Rotator cuff syndromeFAERS: 2US FAERS
383Sinus headacheFAERS: 2US FAERS
384SluggishnessFAERS: 2US FAERS
385Spinal column stenosisFAERS: 2US FAERS
386SpondylolisthesisFAERS: 2US FAERS
387Suicide attemptFAERS: 2US FAERS
388Thermal burnFAERS: 2US FAERS
389Thoracic vertebral fractureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
390Throat clearingFAERS: 2US FAERS
391ThrombocytopeniaFAERS: 2SIDER
US FAERS
392Thrombocytopenic purpuraFAERS: 2US FAERS
393ToothacheFAERS: 2US FAERS
394Transaminases increasedFAERS: 2US FAERS
395Uterine CancerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
396VasculitisFAERS: 2US FAERS
397Vitreous DetachmentFAERS: 2US FAERS
398kyphosisFAERS: 2US FAERS
399Abdominal massFAERS: 1US FAERS
400Abnormal sleep-related eventFAERS: 1US FAERS
401AbscessFAERS: 1US FAERS
402Abstains from alcoholFAERS: 1US FAERS
403Accidental exposure to product packagingFAERS: 1US FAERS
404Accidental overdoseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
405AchlorhydriaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
406Acute Coronary SyndromeFAERS: 1US FAERS
407Acute psychosisFAERS: 1US FAERS
408AgranulocytosisFAERS: 1SIDER
US FAERS
409Allergic respiratory symptomFAERS: 1US FAERS
410Amaurosis FugaxFAERS: 1US FAERS
411AmblyopiaFAERS: 1US FAERS
412Amphetamines positiveFAERS: 1US FAERS
413Anal FissureFAERS: 1US FAERS
414Anal abscessFAERS: 1US FAERS
415Anaphylactoid ReactionFAERS: 1US FAERS
416AneurysmFAERS: 1US FAERS
417Angina PectorisFAERS: 1US FAERS
418Angular cheilitisFAERS: 1US FAERS
419Ankylosing spondylitisFAERS: 1US FAERS
420Aortic AneurysmFAERS: 1US FAERS
421Aortic occlusionFAERS: 1US FAERS
422ApathyFAERS: 1SIDER
US FAERS
423Aphthous StomatitisFAERS: 1US FAERS
424AscitesFAERS: 1US FAERS
425Aspartate Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
426AtelectasisFAERS: 1US FAERS
427Auricular swellingFAERS: 1US FAERS
428Autoimmune neutropeniaFAERS: 1US FAERS
429Autoimmune thrombocytopeniaFAERS: 1US FAERS
430Autoimmune thyroiditisFAERS: 1US FAERS
431BK virus infectionFAERS: 1US FAERS
432Bacterial test positiveFAERS: 1US FAERS
433BedriddenFAERS: 1US FAERS
434Benzodiazepine drug levelFAERS: 1US FAERS
435Biliary dilatationFAERS: 1US FAERS
436Biopsy stomach abnormalFAERS: 1US FAERS
437Biotin deficiencyFAERS: 1US FAERS
438BlepharitisFAERS: 1US FAERS
439Blood albumin decreasedFAERS: 1US FAERS
440Blood cholesterol abnormalFAERS: 1US FAERS
441Blood electrolytes decreasedFAERS: 1US FAERS
442Blood fibrinogen decreasedFAERS: 1US FAERS
443Blood folate decreasedFAERS: 1US FAERS
444Blood magnesium increasedFAERS: 1US FAERS
445Blood parathyroid hormone decreasedFAERS: 1US FAERS
446Blood parathyroid hormone increasedFAERS: 1US FAERS
447Blood potassium abnormalFAERS: 1US FAERS
448Blood potassium increasedFAERS: 1US FAERS
449Blood pressure fluctuationFAERS: 1US FAERS
450Blood prolactin increasedFAERS: 1US FAERS
451Blood testosterone decreasedFAERS: 1US FAERS
452Blood urea increasedFAERS: 1US FAERS
453Bone decalcificationFAERS: 1US FAERS
454Bone fragmentationFAERS: 1US FAERS
455BradycardiaFAERS: 1US FAERS
456Breast cancer recurrentFAERS: 1US FAERS
457Bulimia NervosaFAERS: 1US FAERS
458Campylobacter infectionFAERS: 1US FAERS
459Cardiac FlutterFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
460Catheter site painFAERS: 1US FAERS
461Cauda Equina SyndromeFAERS: 1US FAERS
462Cell DeathFAERS: 1US FAERS
463Cerebral InfarctionFAERS: 1US FAERS
464Cerebral ThrombosisFAERS: 1US FAERS
465Cerebral artery occlusionFAERS: 1US FAERS
466Cerebral disorderFAERS: 1US FAERS
467Cerebrovascular InsufficiencyFAERS: 1US FAERS
468Cervix carcinomaFAERS: 1US FAERS
469Chemical burn of gastrointestinal tractFAERS: 1US FAERS
470CholangiocarcinomaFAERS: 1US FAERS
471CholangitisFAERS: 1US FAERS
472CholecystitisFAERS: 1US FAERS
473CholestasisFAERS: 1US FAERS
474Chronic Fatigue SyndromeFAERS: 1US FAERS
475Clostridium difficile colitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
476ClumsinessFAERS: 1US FAERS
477Congenital hearing disorderFAERS: 1US FAERS
478Contraindicated drug administeredFAERS: 1US FAERS
479Conversion disorderFAERS: 1US FAERS
480Counterfeit product administeredFAERS: 1US FAERS
481Decreased immune responsivenessFAERS: 1US FAERS
482DependenceFAERS: 1US FAERS
483Depression suicidalFAERS: 1US FAERS
484Device dislocationFAERS: 1US FAERS
485Diabetes mellitus inadequate controlFAERS: 1US FAERS
486Diabetic NephropathyFAERS: 1US FAERS
487Diet refusalFAERS: 1US FAERS
488Dilatation intrahepatic duct acquiredFAERS: 1US FAERS
489Diverticular perforationFAERS: 1US FAERS
490Drug ToleranceFAERS: 1US FAERS
491Drug administration errorFAERS: 1US FAERS
492Drug effect variableFAERS: 1US FAERS
493Drug exposure during pregnancyFAERS: 1US FAERS
494Drug level changedFAERS: 1US FAERS
495Drug metabolising enzyme decreasedFAERS: 1US FAERS
496Drug resistanceFAERS: 1US FAERS
497DuodenitisFAERS: 1SIDER
US FAERS
498DysgraphiaFAERS: 1US FAERS
499DysplasiaFAERS: 1SIDER
US FAERS
500Early satietyFAERS: 1US FAERS
501Eating disorder symptomFAERS: 1US FAERS
502Ectopic PregnancyFAERS: 1US FAERS
503Elbow deformityFAERS: 1US FAERS
504Electrocardiogram abnormalFAERS: 1US FAERS
505EnterocolitisFAERS: 1US FAERS
506Enzyme level abnormalFAERS: 1US FAERS
507EpicondylitisFAERS: 1US FAERS
508Erectile dysfunctionFAERS: 1SIDER
US FAERS
509ErythropeniaFAERS: 1US FAERS
510Euphoric moodFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
511Expired drug administeredFAERS: 1US FAERS
512Exposure during breast feedingFAERS: 1US FAERS
513Exposure to toxic agentFAERS: 1US FAERS
514Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 1US FAERS
515Foaming at mouthFAERS: 1US FAERS
516Food PoisoningFAERS: 1US FAERS
517FrustrationFAERS: 1US FAERS
518Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
519Gastric Antral Vascular EctasiaFAERS: 1US FAERS
520Gastric mucosa erythemaFAERS: 1US FAERS
521Gastric mucosal lesionFAERS: 1US FAERS
522Gastric ulcer helicobacterFAERS: 1US FAERS
523GastroenteritisFAERS: 1SIDER
US FAERS
524Gastrointestinal bacterial infectionFAERS: 1US FAERS
525Gastrointestinal candidiasisFAERS: 1SIDER
US FAERS
526Gastrointestinal stenosisFAERS: 1US FAERS
527Gastrointestinal stoma complicationFAERS: 1US FAERS
528General physical conditionFAERS: 1US FAERS
529Granulocyte count decreasedFAERS: 1US FAERS
530Granuloma AnnulareFAERS: 1US FAERS
531Granulomatosis with polyangiitisFAERS: 1US FAERS
532GranulomaFAERS: 1US FAERS
533Hallucinations, mixedFAERS: 1US FAERS
534Hepatic congestionFAERS: 1US FAERS
535Hepatitis CFAERS: 1US FAERS
536HepatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
537HepatomegalyFAERS: 1US FAERS
538HirsutismFAERS: 1US FAERS
539Histamine level increasedFAERS: 1US FAERS
540Hormone level abnormalFAERS: 1US FAERS
541HyperparathyroidismFAERS: 1US FAERS
542HyperthyroidismFAERS: 1US FAERS
543HyperventilationFAERS: 1US FAERS
544HypochondriasisFAERS: 1US FAERS
545HyporeflexiaFAERS: 1US FAERS
546HypoxiaFAERS: 1US FAERS
547Ileal StenosisFAERS: 1US FAERS
548Illness anxiety disorderFAERS: 1US FAERS
549Inappropriate affectFAERS: 1US FAERS
550Incorrect route of drug administrationFAERS: 1US FAERS
551Incorrect route of product administrationFAERS: 1US FAERS
552Incorrect storage of drugFAERS: 1US FAERS
553Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
554Infection in an immunocompromised hostFAERS: 1US FAERS
555Infectious MononucleosisFAERS: 1US FAERS
556Inhibitory drug interactionFAERS: 1US FAERS
557Initial insomniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
558Injection site extravasationFAERS: 1US FAERS
559Injury associated with deviceFAERS: 1US FAERS
560Intercepted drug prescribing errorFAERS: 1US FAERS
561Intervertebral disc disorderFAERS: 1US FAERS
562Intestinal PerforationFAERS: 1US FAERS
563Intestinal cystFAERS: 1US FAERS
564Intrinsic Factor DeficiencyFAERS: 1US FAERS
565Joint laxityFAERS: 1US FAERS
566KetosisFAERS: 1US FAERS
567Laboratory test interferenceFAERS: 1US FAERS
568LeptospirosisFAERS: 1US FAERS
569LichenificationFAERS: 1US FAERS
570Ligament ruptureFAERS: 1US FAERS
571Limb asymmetryFAERS: 1US FAERS
572Lip neoplasm malignant stage unspecifiedFAERS: 1US FAERS
573LipomaFAERS: 1US FAERS
574Liquid product physical issueFAERS: 1US FAERS
575Lower respiratory tract infectionFAERS: 1US FAERS
576Lyme DiseaseFAERS: 1US FAERS
577Lymphangiosis carcinomatosaFAERS: 1US FAERS
578Lymphocyte count decreasedFAERS: 1US FAERS
579LymphopeniaFAERS: 1US FAERS
580Macular degenerationFAERS: 1US FAERS
581MarasmusFAERS: 1US FAERS
582Mastication disorderFAERS: 1US FAERS
583MastocytosisFAERS: 1US FAERS
584Medication ErrorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
585MenopauseFAERS: 1US FAERS
586Mental FatigueFAERS: 1US FAERS
587MetastasisFAERS: 1US FAERS
588Milk soy protein intoleranceFAERS: 1US FAERS
589Mineral deficiencyFAERS: 1US FAERS
590Mineral supplementationFAERS: 1US FAERS
591Mood swingsFAERS: 1US FAERS
592Motion SicknessFAERS: 1US FAERS
593Mucosal erosionFAERS: 1US FAERS
594Muscle RigidityFAERS: 1US FAERS
595Muscle strainFAERS: 1US FAERS
596Muscular DystrophyFAERS: 1US FAERS
597MyelofibrosisFAERS: 1US FAERS
598MyocarditisFAERS: 1US FAERS
599MyopathyFAERS: 1US FAERS
600MyositisFAERS: 1US FAERS
601Nasopharyngeal refluxFAERS: 1US FAERS
602NephritisFAERS: 1US FAERS
603ObesityFAERS: 1US FAERS
604Ocular vascular disorderFAERS: 1US FAERS
605Oculomucocutaneous syndromeFAERS: 1US FAERS
606OliguriaFAERS: 1US FAERS
607OpisthotonusFAERS: 1US FAERS
608Oropharyngeal spasmFAERS: 1US FAERS
609Oropharyngeal swellingFAERS: 1US FAERS
610OsteitisFAERS: 1US FAERS
611Overgrowth fungalFAERS: 1US FAERS
612Pain of skinFAERS: 1US FAERS
613PallorFAERS: 1US FAERS
614Patellofemoral Pain SyndromeFAERS: 1US FAERS
615Pelvic PainFAERS: 1US FAERS
616Perforated ulcerFAERS: 1US FAERS
617Performance status decreasedFAERS: 1US FAERS
618PericarditisFAERS: 1US FAERS
619Peripheral nerve lesionFAERS: 1US FAERS
620Personality ChangeFAERS: 1US FAERS
621Pharyngeal erosionFAERS: 1US FAERS
622PhotophobiaFAERS: 1US FAERS
623Physical disabilityFAERS: 1US FAERS
624Physical product label issueFAERS: 1US FAERS
625PiloerectionFAERS: 1US FAERS
626PleurisyFAERS: 1US FAERS
627PoisoningFAERS: 1US FAERS
628Poor peripheral circulationFAERS: 1US FAERS
629Portal HypertensionFAERS: 1US FAERS
630Post procedural infectionFAERS: 1US FAERS
631Post-traumatic neck syndromeFAERS: 1US FAERS
632Pre-EclampsiaFAERS: 1US FAERS
633PregnancyFAERS: 1US FAERS
634Prescribed overdoseFAERS: 1US FAERS
635Prescription drug used without a prescriptionFAERS: 1US FAERS
636PresyncopeFAERS: 1US FAERS
637Primary Biliary CholangitisFAERS: 1US FAERS
638ProctitisFAERS: 1US FAERS
639Product complaintFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
640Product contamination physicalFAERS: 1US FAERS
641Product dispensing errorFAERS: 1US FAERS
642Product formulation issueFAERS: 1US FAERS
643Product impurityFAERS: 1US FAERS
644Product packaging confusionFAERS: 1US FAERS
645Product packaging quantity issueFAERS: 1US FAERS
646Product physical consistency issueFAERS: 1US FAERS
647Product preparation errorFAERS: 1US FAERS
648Product prescribing issueFAERS: 1US FAERS
649Product storage errorFAERS: 1US FAERS
650Product use complaintFAERS: 1US FAERS
651Protein total decreasedFAERS: 1US FAERS
652Pulmonary HypertensionFAERS: 1US FAERS
653PurulenceFAERS: 1US FAERS
654Rash erythematousFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
655Reaction to excipientFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
656Rectal ProlapseFAERS: 1US FAERS
657Reflux laryngitisFAERS: 1US FAERS
658Renal Cell CarcinomaFAERS: 1US FAERS
659Renal tubular acidosisFAERS: 1US FAERS
660Renal tubular injuryFAERS: 1US FAERS
661Respiratory distressFAERS: 1US FAERS
662Restless Legs SyndromeFAERS: 1US FAERS
663Retinal DegenerationFAERS: 1US FAERS
664Retinal vascular thrombosisFAERS: 1US FAERS
665Rheumatoid factor increasedFAERS: 1US FAERS
666RosaceaFAERS: 1US FAERS
667Saliva alteredFAERS: 1US FAERS
668ScabFAERS: 1US FAERS
669SchizophreniaFAERS: 1US FAERS
670Secretion dischargeFAERS: 1US FAERS
671Sinus perforationFAERS: 1US FAERS
672Skeletal injuryFAERS: 1US FAERS
673Skin lesionFAERS: 1US FAERS
674Skin reactionFAERS: 1US FAERS
675Sleep-related eating disorderFAERS: 1US FAERS
676Small intestinal bacterial overgrowthFAERS: 1US FAERS
677Spinal StenosisFAERS: 1US FAERS
678Spinal fusion acquiredFAERS: 1US FAERS
679SpondylolysisFAERS: 1US FAERS
680Stevens-Johnson SyndromeFAERS: 1
Canada Vigilance: 1
25811541CTD
SIDER
Canada Vigilance
US FAERS
681Supraventricular tachycardiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
682Suture insertionFAERS: 1US FAERS
683Suture related complicationFAERS: 1US FAERS
684SynovitisFAERS: 1US FAERS
685Systemic SclerodermaFAERS: 1US FAERS
686TachyphreniaFAERS: 1US FAERS
687TachyphylaxisFAERS: 1US FAERS
688Tension HeadacheFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
689TensionFAERS: 1SIDER
US FAERS
690Terminal stateFAERS: 1US FAERS
691Therapeutic product ineffectiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
692Therapy changeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
693Thyroid NeoplasmFAERS: 1US FAERS
694Tongue eruptionFAERS: 1US FAERS
695Tooth InfectionFAERS: 1US FAERS
696TorticollisFAERS: 1US FAERS
697Toxicity to various agentsFAERS: 1US FAERS
698Tracheostomy malfunctionFAERS: 1US FAERS
699Transcription medication errorFAERS: 1US FAERS
700TrismusFAERS: 1US FAERS
701Tumour haemorrhageFAERS: 1US FAERS
702Umbilical herniaFAERS: 1US FAERS
703Unresponsive to stimuliFAERS: 1US FAERS
704Upper respiratory tract congestionFAERS: 1US FAERS
705Urinary IncontinenceFAERS: 1US FAERS
706Urinary tract infection fungalFAERS: 1US FAERS
707Vagus Nerve DisorderFAERS: 1US FAERS
708Vascular calcificationFAERS: 1US FAERS
709Vascular ruptureFAERS: 1US FAERS
710Venous ThrombosisFAERS: 1US FAERS
711Venous occlusionFAERS: 1US FAERS
712Vitamin B6 decreasedFAERS: 1US FAERS
713Vitamin D abnormalFAERS: 1US FAERS
714Vitreous floatersFAERS: 1US FAERS
715Vocal Cord ParalysisFAERS: 1US FAERS
716Vocal cord cystFAERS: 1US FAERS
717Vulvovaginal drynessFAERS: 1US FAERS
718Water IntoxicationFAERS: 1US FAERS
719Wrong technique in drug usage processFAERS: 1US FAERS
720YawningFAERS: 1US FAERS
721muscle injuryFAERS: 1US FAERS
722prostatitisFAERS: 1US FAERS
723treatment failureFAERS: 1US FAERS
724Abnormal visionSIDER
725Alanine Aminotransferase IncreasedSIDER
726AlbuminuriaSIDER
727AnorexiaSIDER
728Arthritis aggravatedSIDER
729Asthma aggravatedSIDER
730Bladder painSIDER
731Blood alkaline phosphatase increasedSIDER
732Cleft PalateCanada Vigilance: 1Canada Vigilance
733ConjunctivitisSIDER
734Constipation aggravatedSIDER
735Creatinine increasedSIDER
736Depression aggravatedSIDER
737Enlargement abdomenSIDER
738EosinophiliaCanada Vigilance: 1Canada Vigilance
739Eosinophilic FasciitisCanada Vigilance: 1Canada Vigilance
740Epigastric painSIDER
741Flat affectSIDER
742Gait inabilityCanada Vigilance: 1Canada Vigilance
743GlycosuriaSIDER
744Head discomfortCanada Vigilance: 1Canada Vigilance
745Hepatic EncephalopathySIDER
746IleusCanada Vigilance: 1Canada Vigilance
747Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
748InfertilityCanada Vigilance: 1Canada Vigilance
749InfestationSIDER
750Leg edemaSIDER
751LeukocytosisSIDER
752LymphadenopathySIDER
753Migraine aggravatedSIDER
754Oral administration complicationCanada Vigilance: 1Canada Vigilance
755Oral mucosal eruptionCanada Vigilance: 1Canada Vigilance
756Otitis MediaSIDER
757Polymyalgia RheumaticaSIDER
758PolyuriaSIDER
759Product compounding quality issueCanada Vigilance: 1Canada Vigilance
760Product size issueCanada Vigilance: 1Canada Vigilance
761Product substitutionCanada Vigilance: 1Canada Vigilance
762Product used for unknown indicationCanada Vigilance: 1Canada Vigilance
763Retrosternal painSIDER
764RhinitisSIDER
765ScotomaSIDER
766Serum gastrin increasedSIDER
767ShockSIDER
768Therapeutic product effect decreasedCanada Vigilance: 3Canada Vigilance
769Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
770Therapy non-responderCanada Vigilance: 1Canada Vigilance
771Tongue discomfortCanada Vigilance: 1Canada Vigilance
772Ulcerative stomatitisSIDER
773Urine output increasedSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.